Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
Holly C. Hunsberger, Priyanka D. Pinky, Warren E. Smith, et al.
Neuronal Signaling (2019) Vol. 3, Iss. 2
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 22
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort
Silvia Ingala, Casper de Boer, Larissa A Masselink, et al.
Alzheimer s & Dementia (2021) Vol. 17, Iss. 7, pp. 1189-1204
Open Access | Times Cited: 62
Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
Michail Michailidis, Despina Α. Tata, Despina Μoraitou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4641-4641
Open Access | Times Cited: 51
Pharmacological Approaches Using Diabetic Drugs Repurposed for Alzheimer’s Disease
Muna A. Adem, Boris Decourt, Marwan N. Sabbagh
Biomedicines (2024) Vol. 12, Iss. 1, pp. 99-99
Open Access | Times Cited: 15
ENHANCE: a comparative prospective longitudinal study of cognitive outcomes after 3 years of hearing aid use in older adults
Julia Sarant, Peter A. Busby, Adrian Schembri, et al.
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 12
APOE ε4 is associated with decreased synaptic density in cognitively impaired participants
Kun He, Binyin Li, Jie Wang, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3157-3166
Open Access | Times Cited: 12
Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice
André Miguel Miranda, Archana Ashok, Robin Chan, et al.
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 36
Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer’s dementia
Brandon Ebright, Isaac Assante, R Poblete, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 32
From degenerative disease to malignant tumors: Insight to the function of ApoE
Ganggang Miao, Danping Zhuo, Xue Han, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 158, pp. 114127-114127
Open Access | Times Cited: 32
Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease
Chinenye Edith Muolokwu, Bivek Chaulagain, Avinash Gothwal, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
The Role of Estrogen across Multiple Disease Mechanisms
Xiuting Xiang, Praneetha Palasuberniam, Rahmawati Pare
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8170-8196
Open Access | Times Cited: 6
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases
Karolina Minta, G. Brinkmalm, Shorena Janelidze, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 40
Natural products as potential modulators of pro-inflammatory cytokines signalling in Alzheimer's disease
Vikas Yadav, C Mythri, Murali Kumarasamy
Brain Behavior and Immunity Integrative (2024) Vol. 5, pp. 100048-100048
Open Access | Times Cited: 5
Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease
Vivek Sharma, Thakur Gurjeet Singh
Life Sciences (2020) Vol. 262, pp. 118401-118401
Closed Access | Times Cited: 39
Novel therapeutic strategies for Alzheimer’s disease targeting brain cholesterol homeostasis
Nikita Patil Samant, Girdhari Lal Gupta
European Journal of Neuroscience (2020) Vol. 53, Iss. 2, pp. 673-686
Closed Access | Times Cited: 33
Unraveling the role of plasma proteins in dementia: insights from two cohort studies in the UK, with causal evidence from Mendelian randomization
Jessica Gong, Dylan M. Williams, Shaun Scholes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Cholesterol and Dementia: A Long and Complicated Relationship
Oliwia McFarlane, Kornelia Kędziora–Kornatowska
Current Aging Science (2019) Vol. 13, Iss. 1, pp. 42-51
Open Access | Times Cited: 31
Protein degradation-associated mechanisms that are affected in Alzheimer´s disease
Ángeles C. Tecalco-Cruz, José Pedraza-Chaverrı́, Alfredo Briones‐Herrera, et al.
Molecular and Cellular Biochemistry (2022) Vol. 477, Iss. 3, pp. 915-925
Closed Access | Times Cited: 17
APOE genotype and sex modulate Alzheimer’s disease pathology in aged EFAD transgenic mice
Deebika Balu, Ana C. Valencia‐Olvera, Zarak Islam, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 10
AOP report: Development of an adverse outcome pathway for deposition of energy leading to learning and memory impairment
Ahmad Sleiman, Kathleen B. Miller, Danicia Flores, et al.
Environmental and Molecular Mutagenesis (2024) Vol. 65, Iss. S3, pp. 57-84
Open Access | Times Cited: 3
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access
Unraveling the role of proteins in dementia: insights from two UK cohorts with causal evidence
Jessica Gong, Dylan M. Williams, Shaun Scholes, et al.
Brain Communications (2025) Vol. 7, Iss. 2
Open Access
Structural changes to the basal forebrain cholinergic system in the continuum of Alzheimer disease
Miriam Taza, Taylor W. Schmitz, R. Nathan Spreng
Handbook of clinical neurology (2025), pp. 81-93
Closed Access
Impact of New Drugs for Therapeutic Intervention in Alzheimer’s Disease
Jordi Olloquequi, Miren Ettcheto, Amanda Cano, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 5, pp. 146-146
Open Access | Times Cited: 16
Hippocampus-centred grey matter covariance networks predict the development and reversion of mild cognitive impairment
Mingxi Dang, Caishui Yang, Kewei Chen, et al.
Alzheimer s Research & Therapy (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top